Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06578650 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Prospective, Single-arm, Clinical Trial of Electrospun Fiber Matrix (Restrata) in the Treatment of Surgical Defects Secondary to Resection of Malignant Cutaneous Neoplasms

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Notable Primary completion date: Nov 2026 to Aug 2027
    • Study completion date: May 2027 to Oct 2027
    v9
  2. Notable Primary completion date: Oct 2025 to Nov 2026
    • Study completion date: Apr 2026 to May 2027
    v8
  3. Minor Primary completion date: Apr 2025 to Oct 2025
    • Study completion date: Aug 2025 to Apr 2026
    v7
  4. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Oct 2024 to Oct 31, 2024
    • Site details revised
    v6
  5. Minor Start date: Sep 2024 to Oct 2024
    • Site contact updated
    v5
Show 3 earlier versionsHide 3 earlier versions
  1. Minor Study sites: 0 to 1v4
  2. Minor 2 versions Re-verified since Aug 29, 2024, no change to tracked fieldsv2-v3
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this observational prospective study is to evaluate wound healing outcomes in resection wounds resulting from surgical removal of cutaneous malignancies treated with a synthetic electrospun fiber matrix. This study intends to quantify the time from initial resection and product application to time of complete granulation of the wound bed in weeks.
Trial Details
NCT Number NCT06578650
Lead Sponsor Acera Surgical, Inc.
Conditions
(from sponsor)
Surgical Wound
Related terms Surgical Wound
Enrollment 34 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov